Skip to main content
FAQs
Glossary
Close
FAQs
Why are some conditions more suitable for gene and cell therapies than others?
There is an approved treatment available for my condition - why can't I receive it?
How to look for approved medicines?
How are medicines developed and approved?
See all FAQs
Close
Glossary
Adeno-associated virus (AAV)
Adenovirus
Adult stem cells
Antibody
Antigen
Base editors
Cas9 nuclease
Chimeric Antigen Receptor (CAR)
Chromosome
Clinical trial
See full Glossary
EuroGCT
Menu
Close
Select language
English
Français
Deutsch
Italiano
Polski
Español
Português
Main navigation
Discover
Discover
Discover Gene and Cell Therapy
Educational Resources Directory
Educational Resources Directory
INTENS
INtestinal Tissue ENgineering Solution
LEARN
Listening to the experience of participants in neurosurgical trials
Discover Gene and Cell Therapy
Research Pathways
Research Pathways
Bringing new therapies from the lab to patients
EuroGCT Key Resources
EuroGCT Key Resources
ATMP Engage
Advanced Therapy Medicinal Products Patient and Public Involvement and Engagement Working Group
Actors and Network database
Actors and Network database
Bringing new therapies from the lab to patients
About Us
Our team and partners
Contact
Condition
Alzheimer's Disease
Blood disorders
Bowel Disease
Cancer
Cerebral Palsy
Cord Blood
Cystic Fibrosis
Diabetes
Epidermolysis Bullosa
Eye Disease
Heart Disease
Huntington's Disease
Immune Conditions
Kidney Disease
Liver Disease
Lung Disease
Motor Neurone Disease
Multiple Sclerosis
Muscle and Skeletal Diseases
Muscular Dystrophy
Neurological Disorders
Parkinson's Disease
Rare Diseases
Sickle Cell Disease
Skin
Spinal Cord Injuries
Spinal Muscular Atrophy
Stroke
Reproduction and Fertility
Theme
Blood Stem Cells
CAR-T Therapy
Cell and Gene Fundamentals
Cell Therapy
Clinical Trials
Cord Blood
Current and Potential Uses
Disease Modelling
Embryonic Stem Cells
Ethics and Society
Explore Stem Cells
Factsheets
Gene Editing
Gene Therapy
Industry
iPS cells
Methods and Tools
MSCs
Organoids
Patient Involvement
Policy & Regulation
Reprogramming
Research
Skin Stem Cells
Spotlight on Research
Stem Cell News
Tissue Engineering
Unproven Treatments
Search
Select language
English
Français
Deutsch
Italiano
Polski
Español
Português
Breadcrumb
Home
Ethics and Society
Ethics and Society
Resources & Factsheets
EuroGCT Resource
What are 'unproven' therapies?
Related Topics
Clinical Trials
Current and Potential Uses
Ethics and Society
Factsheets
MSCs
Policy & Regulation
Unproven Treatments
English
Growing support for gene and cell therapies in Germany
Related Topics
Cell Therapy
Ethics and Society
Gene Therapy
Policy & Regulation
Genetics Shambles
Related Topics
Cell and Gene Fundamentals
Ethics and Society
Explore Stem Cells
Gene Editing
Gene Therapy
Research
International Guidelines for the Treatment of Huntington's Disease
Related Topics
Huntington's Disease
Neurological Disorders
Current and Potential Uses
Ethics and Society
Alzheimer's Society UK: Legal and financial issues for people living with dementia in the UK
Related Topics
Alzheimer's Disease
Neurological Disorders
Ethics and Society
EuroGCT Resource
Where should I start?
Related Topics
Cell and Gene Fundamentals
Cell Therapy
Clinical Trials
Current and Potential Uses
Ethics and Society
Gene Therapy
Methods and Tools
Patient Involvement
Policy & Regulation
Research
EuroGCT Resource
There is an approved treatment available for my condition - why can't I receive it?
Related Topics
Rare Diseases
Clinical Trials
Current and Potential Uses
Ethics and Society
Industry
Policy & Regulation
Unproven Treatments
ATMP Engage working groups
Related Topics
Ethics and Society
Patient Involvement
Policy & Regulation
EuroGCT Resource
Why are some conditions more suitable for gene and cell therapies than others?
Related Topics
Cell Therapy
Clinical Trials
Current and Potential Uses
Disease Modelling
Ethics and Society
Gene Editing
Gene Therapy
Methods and Tools
Patient Involvement
Policy & Regulation
Research
English
European Reference Networks
Related Topics
Current and Potential Uses
Ethics and Society
Policy & Regulation
Pagination
Page
1
Page
2
Next page
››
Last page
Last »
Back to top